"Head and neck cancer squamous cell carcinoma" trang 1 - tải miễn phí từ tailieunhanh
Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort
10    27    1
Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma

Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma
14    69    1
Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma

Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma
11    61    1
Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth

Central neck lymph node metastasis in oral squamous cell carcinoma at the floor of mouth
7    42    1
Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: Retrospective cohort study

Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: Retrospective cohort study
8    83    1
Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma

Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma
13    9    1
Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

Rationale and design of LUX-Head & Neck 1: A randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy
9    74    1
Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma

Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma
12    66    1
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: A randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: A randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen
10    61    1
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-Lalanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells

5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-Lalanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
14    76    1
Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt
14    55    1
Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma

Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma
10    73    1
Wilms’ tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck

Wilms’ tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck
12    55    1
Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck
9    53    1
Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: A nationwide retrospective cohort study (KCSG HN13–01)
9    45    1
Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma

Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma
15    45    1
Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma

Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma
19    16    1
A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): A single arm clinical trial protocol

A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): A single arm clinical trial protocol
10    7    1
Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma

Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma
9    1    1
Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: A real-world data analysis

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: A real-world data analysis
9    1    1